Transduction of an IL-2 Gene into Human Melanoma-Reactive Lymphocytes Results in Their Continued Growth in the Absence of Exogenous IL-2 and Maintenance of Specific Antitumor Activity

Ítems similars

• Interleukin-2–Independent Proliferation of Human Melanoma-Reactive T Lymphocytes Transduced With an Exogenous IL-2 Gene Is Stimulation Dependent
  per: Liu, Ke, et al.
  Publicat: (2003)
• Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes
  per: Rosenberg, Steven A., et al.
  Publicat: (2004)
• Transcription activator-like effector nuclease-mediated transduction of exogenous gene into IL2RG locus
  per: Matsubara, Yohei, et al.
  Publicat: (2014)
• Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB(389)IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With Melanoma
  per: Attia, Peter, et al.
  Publicat: (2005)
• Primary Human T Lymphocytes Engineered with a Codon-Optimized IL-15 Gene Resist Cytokine Withdrawal-Induced Apoptosis and Persist Long-Term in the Absence of Exogenous Cytokine
  per: Hsu, Cary, et al.
  Publicat: (2005)